NCT01138189

Brief Summary

The purpose of the study is to compare the results of LASIK surgery when using wavefront-guided excimer laser treatment compared to wavefront optimized excimer laser treatment in patients with nearsightedness with and without astigmatism

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2010

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 6, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 3, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 7, 2010

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2012

Completed
Last Updated

December 8, 2021

Status Verified

November 1, 2021

Enrollment Period

2.1 years

First QC Date

June 3, 2010

Last Update Submit

November 24, 2021

Conditions

Keywords

Wavefront-guided LASIK.Wavefront-optimized LASIK.Custom LASIK

Outcome Measures

Primary Outcomes (4)

  • Changes in best corrected visual acuity

    12 months

  • Changes in 5 and 25% contrast visual acuity

    12 months

  • Refractive predictability

    12 months

  • Uncorrected visual acuity

    12 months

Secondary Outcomes (3)

  • Changes in higher order aberrations

    1 yr

  • Quality of vision measurement

    1 yr

  • Topographic analysis

    1 yr

Interventions

Wavefront-guided LASIK in one eye using the Allegretto excimer laser

Also known as: Wavelight Allegretto Eye-Q 400 Hz excimer laser

Wavefront-optimized LASIK in one eye using the Allegretto excimer laser

Also known as: Wavelight Allegretto Eye-Q 400 Hz excimer laser

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects age 21 and older with healthy eyes. Nearsightedness between -7.50 diopters and -7.00 diopters with or without astigmatism of up to 3.50 diopters.

You may qualify if:

  • Subjects age 21 and older with healthy eyes.
  • Nearsightedness between -7.50 diopters and -7.00 diopters with or without astigmatism of up to 3.50 diopters.

You may not qualify if:

  • Subjects under the age of 21.
  • Patients with excessively thin corneas.
  • Patients with topographic evidence of keratoconus.
  • Patients with autoimmune diseases.
  • Patients who are pregnant or nursing.
  • Patients must have similar levels of nearsightedness in each eye. They can not be more than 3.0 diopter of difference between eyes.
  • Patients must have similar levels of astigmatism in each eye. They can not have more than 4.0 diopters of difference in nearsightedness or astigmatism between their two eyes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

Related Publications (1)

  • Sales CS, Manche EE. One-year outcomes from a prospective, randomized, eye-to-eye comparison of wavefront-guided and wavefront-optimized LASIK in myopes. Ophthalmology. 2013 Dec;120(12):2396-2402. doi: 10.1016/j.ophtha.2013.05.010. Epub 2013 Jun 15.

MeSH Terms

Conditions

MyopiaAstigmatism

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Edward E. Manche

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Stanford University School of Medicine

Study Record Dates

First Submitted

June 3, 2010

First Posted

June 7, 2010

Study Start

April 6, 2010

Primary Completion

April 30, 2012

Study Completion

April 30, 2012

Last Updated

December 8, 2021

Record last verified: 2021-11

Locations